Telomir Pharmaceuticals, Inc.

Healthcare · Biotechnology · United States

Last price 0.9352 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 68.85M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Telomir Pharmaceuticals, Inc., a preclinical-stage biotechnology company, focuses on the development of small-molecule therapeutics designed to address upstream biological drivers of aging and age-related diseases. It is developing Telomir-1, an oral small molecule metal ion regulator designed to protect against age-related conditions, including Wilson’s disease, Type 2 diabetes, age-related macular degeneration (AMD), oncology, and epigenetic regulation, as well as Alzheimer’s disease and Progeria. The company was formerly known as Metallo The...